Mar 14, 2024 8:00am EDT Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024
Mar 06, 2024 8:00am EST Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Feb 29, 2024 8:01am EST Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission
Feb 29, 2024 8:00am EST Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement
Dec 11, 2023 4:30pm EST Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Nov 09, 2023 4:00pm EST Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update
Oct 26, 2023 8:00am EDT Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023
Oct 03, 2023 8:00am EDT Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Sep 11, 2023 8:00am EDT Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting
Sep 07, 2023 8:00am EDT Achieve Life Sciences Announces Participation at Upcoming Investor Conferences